Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1959 Oct 31;2(5156):841–847. doi: 10.1136/bmj.2.5156.841

Further Experience with Oral Therapy in Diabetes

K L Granville-Grossman, S Crawfurd, Mary F Crowley, Arnold Bloom
PMCID: PMC1990379  PMID: 13828985

Full text

PDF
841

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CROWLEY M. F., WOLFF F. W., BLOOM A. Tolbutamide in diabetes; some clinical and biochemical studies. Br Med J. 1957 Aug 10;2(5040):327–331. doi: 10.1136/bmj.2.5040.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. DUNCAN L. J., BAIRD J. D., DUNLOP D. M. A clinical trial of BZ 55. Br Med J. 1956 Aug 25;2(4990):433–439. doi: 10.1136/bmj.2.4990.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. HADLEY W. B., KHACHADURIAN A., MARBLE A. Studies with chlorpropamide in diabetic patients. Ann N Y Acad Sci. 1959 Mar 30;74(3):621–624. doi: 10.1111/j.1749-6632.1959.tb39587.x. [DOI] [PubMed] [Google Scholar]
  4. HALL G. H., CROWLEY M. F., BLOOM A. Oral treatment of diabetes; trail of phenethyldiguanide (D.B.I.). Br Med J. 1958 Jul 12;2(5088):71–74. doi: 10.1136/bmj.2.5088.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. KEMSLEY W. F. F. Body weight at different ages and heights. Ann Eugen. 1952 May;16(4):316–334. doi: 10.1111/j.1469-1809.1951.tb02484.x. [DOI] [PubMed] [Google Scholar]
  6. KNAUFF R. E., FAJANS S. S., RAMIREZ E., CONN J. W. Metabolic studies of chlorpropamide in normal men and in diabetic subjects. Ann N Y Acad Sci. 1959 Mar 30;74(3):603–617. doi: 10.1111/j.1749-6632.1959.tb39585.x. [DOI] [PubMed] [Google Scholar]
  7. MARBLE A. Oral hypoglycemic agents in the management of diabete. Med Clin North Am. 1958 Sep;42(5):1163–1177. doi: 10.1016/s0025-7125(16)34215-8. [DOI] [PubMed] [Google Scholar]
  8. MURRAY I., RIDDELL M. J., WANG I. Chlorpropamide; a new hypoglycaemic agent. Lancet. 1958 Sep 13;2(7046):553–554. doi: 10.1016/s0140-6736(58)90197-1. [DOI] [PubMed] [Google Scholar]
  9. SMITH A. J., DUBE A. H. Chlorpropamide therapy in diabetic patients. N Y State J Med. 1958 Nov 15;58(22):3631–3634. [PubMed] [Google Scholar]
  10. STOWERS J. M., CONSTABLE L. W., HUNTER R. B. A clinical and pharmacological comparison of chlorpropamide and other sulfonylureas. Ann N Y Acad Sci. 1959 Mar 30;74(3):689–695. doi: 10.1111/j.1749-6632.1959.tb39597.x. [DOI] [PubMed] [Google Scholar]
  11. STOWERS J. M., MAHLER R. F., HUNTER R. B. Pharmacology and mode of action of the sulphonylureas in man. Lancet. 1958 Feb 8;1(7015):278–283. doi: 10.1016/s0140-6736(58)91028-6. [DOI] [PubMed] [Google Scholar]
  12. SUGAR S. J., THOMAS L. J., TATLIER S. Management of diabetes mellitus with chlorpropamide; preliminary report. Med Ann Dist Columbia. 1958 Sep;27(9):445–passim. [PubMed] [Google Scholar]
  13. TORNOW A. M., ZINKE M. R., GREENBERG P., LEEVY C. M. Hypoglycemic effects of 1-(p-chlorobenzenesulfonyl)-3-n-propylurea; observations in man. Diabetes. 1959 Jan-Feb;8(1):1–6. doi: 10.2337/diab.8.1.1. [DOI] [PubMed] [Google Scholar]
  14. UNGAR G., FREEDMAN L., SHAPIRO S. L. Pharmacological studies of a new oral hypoglycemic drug. Proc Soc Exp Biol Med. 1957 May;95(1):190–192. doi: 10.3181/00379727-95-23163. [DOI] [PubMed] [Google Scholar]
  15. WEST K. M., McCAMPBELL S. R. Hypoglycemic potency in man of a new sulfonylurea derivative (chlorpropamide). Proc Soc Exp Biol Med. 1958 Aug-Sep;98(4):724–725. doi: 10.3181/00379727-98-24163. [DOI] [PubMed] [Google Scholar]
  16. WILLIAMS R. H., TYBERGHEIN J. M., HYDE P. M., NIELSEN R. L. Studies related to the hypoglycemic action of phenethyldiguanide. Metabolism. 1957 Jul;6(4):311–319. [PubMed] [Google Scholar]
  17. WOLFF F. W., STEWART G. A., CROWLEY M. F., BLOOM A. Trial of an oral hypoglycaemic agent in diabetes. Br Med J. 1956 Aug 25;2(4990):440–445. doi: 10.1136/bmj.2.4990.440. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES